By Donald Zuhn --
Last week, Dow Jones VentureSource reported that investors put $6.4 billion of venture capital into 661 deals in the first quarter of 2011, which constituted a 35% increase in funding and a 5% increase in deals as compared with the same period last year. VentureSource noted that corporations provided $448 million of the $6.4 billion raised by venture-backed companies and were responsible for three of the ten largest deals of the first quarter.
In the healthcare sector, the VentureSource report indicated that while funding rose 21% to $1.6 billion, the number of deals dropped 6% to 148 in the first quarter of 2011 over the same period last year. Of the industries making up the healthcare sector, biopharmaceuticals collected 53% ($849 million) of healthcare funding and was responsible for 41% (61) of the sector's deals, which constituted a 15% increase in capital and a 13% drop in deals. The information technology sector matched the healthcare sector's $1.6 billion in funding in the first quarter.
Earlier this month, the National Venture Capital Association (NVCA) released its own report on venture funding, which indicated that $5.9 billion had been invested in 736 deals in the first quarter (see "NVCA Reports Modest Gains in First Quarter Venture Funding"). The NVCA report also noted that $1.4 billion had been invested in 164 first quarter deals in the Life Sciences sector (which like VentureSource's healthcare sector consists primarily of biotech and medical device companies).
Information technology sector matched healthcare sector.. how it is possible.. Can anyone suggest me..
Posted by: pharmaceutical generics | April 27, 2011 at 06:58 AM